| Literature DB >> 32207066 |
Hidefumi Mimura1, Sadanori Akita2, Akihiro Fujino3, Masatoshi Jinnin4, Mine Ozaki5, Keigo Osuga6, Hiroki Nakaoka7, Eiichi Morii8, Akira Kuramochi9, Yoko Aoki10, Yasunori Arai11, Noriko Aramaki12, Masanori Inoue13, Yuki Iwashina5, Tadashi Iwanaka14, Shigeru Ueno15, Akihiro Umezawa16, Michio Ozeki17, Junko Ochi18, Yoshiaki Kinoshita19, Masakazu Kurita20, Shien Seike21, Nobuyuki Takakura22, Masataka Takahashi16, Takao Tachibana23, Kumiko Chuman24, Shuji Nagata25, Mitsunaga Narushima26, Yasunari Niimi27, Shunsuke Nosaka28, Taiki Nozaki29, Kazuki Hashimoto11, Ayato Hayashi30, Satoshi Hirakawa31, Atsuko Fujikawa11, Yumiko Hori8, Kentaro Matsuoka32, Hideki Mori7, Yuki Yamamoto4, Shunsuke Yuzuriha33, Naoaki Rikihisa34, Shoji Watanabe35, Shinichi Watanabe36, Tatsuo Kuroda37, Shunsuke Sugawara38, Kosuke Ishikawa39, Satoru Sasaki40.
Abstract
The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.Entities:
Keywords: Clinical practice; Guidelines; Hemangioma; Vascular anomalies; Vascular malformation
Mesh:
Year: 2020 PMID: 32207066 PMCID: PMC7150662 DOI: 10.1007/s11604-019-00885-5
Source DB: PubMed Journal: Jpn J Radiol ISSN: 1867-1071 Impact factor: 2.374